Novel therapies for high-risk MDS Published 2021-06-11 Download video MP4 360p Download video MP4 720p Recommendations 33:19 MDS - Myeloplastic Syndromes - 2023 Best of Hematology Conference 01:53 An update on the progress made in CAR T-cell therapy in India 03:14 Are all-oral-based induction combinations the future for AML treatment? 04:08 The risk of secondary primary malignancy after CAR-T therapy: a retrospective analysis 03:38 How serious a cancer is MDS? What is the prognosis for MDS? 01:14 Components of the CAR-HEMATOTOX model which allow for prediction of ICAHT following CAR-T 01:25 Prognosis and treatment in high-risk MDS 03:45 Risk Factors for Disease Progression in Patients with Polycythemia Vera 04:27 What are the treatments for low risk and high risk MDS? #MDS 03:22 Is TP53-mutated high-risk MDS the same disease as TP53-mutated AML? 09:15 Caffeine, Health, and the Human Body 01:03 Cognitive impairment in patients receiving CAR T-cell therapy 45:50 Treating Persistent/Chronic ITP Current Care, Future Potential 04:39 David's story: How did you find out you had MDS? 14:14 Killer Klebsiella 47:37 Microdosing: Fact or Fiction? - UC Davis Psychedelic Summit 2023 03:46 'Clinical case discussions' session rundown: HLH/MAS, aseptic meningitis, & CAR-NK cells in MM 01:32 Factors contributing to the pathogenesis of ICAHT 01:28 Donna's story: What has been the greatest success with your MDS treatment? 02:07 Targeting BAFF-R with CAR-Ts to treat MCL Similar videos 02:13 Optimizing therapy for patients with high-risk MDS 02:43 Novel therapies in the future of MDS treatment 18:14 Novel Treatment Strategies in Low-Risk MDS: Challenges and Emerging Therapies 04:12 Novel therapies in low-risk MDS 01:34 Managing adverse events with novel therapies in lower-risk MDS 1:01:10 Aplastic anemia management: what's new? 02:16 Updates in the Myelodysplastic Syndromes: 2023 Best of Hematology 09:29 MDS/AML Overlap and Novel Therapies with Dr. Naval Daver 33:29 Higher-risk MDS and AML: How new guidelines are changing diagnosis, classification and management 02:54 Novel therapies in AML and MDS 03:08 The treatment protocol for higher risk MDS 01:21 Future treatment priorities for high-risk MDS 03:24 Novel agents in higher-risk MDS 18:42 Novel Treatment Strategies in Low-Risk MDS: Case Study 01:45 Updates on the treatment of MDS 25:33 MDS – New and Emerging Treatments 1:32:06 High Risk MDS Treatment Strategies More results